SAN FRANCISCO (KGO) -- As we first reported on ABC7 News, a Phase 3 trial for the AstraZeneca vaccine will begin in the Bay Area this month. It's one of six companies that are part of the U.S. government's Operation Warp Speed to develop a vaccine.
San Francisco's Department of Public Health is encouraging people to volunteer for the AstraZeneca trial, so in order to get an idea of what participants might be able to expect, ABC7 news reporter Kate Larsen spoke to the first people ever injected with a trial vaccine in the U.S.
Jennifer, Neal, Ian and Judy, are all enrolled in trials for the COVID-19 vaccine developed by Massachusetts-based biotech company Moderna and the federal government.
On March 16, Seattle resident, Jennifer Haller was the first person in the U.S. to get injected with the experimental vaccine.
VIDEO: What are risks of rushing a COVID-19 vaccine? Former FDA chief scientist weighs in
"Looking back at the time with hindsight now, I realize how important it really was," said Haller.
Neal Browning was second in line for the Phase 1 trial, which took place in the Seattle area.
"Initially there was some trepidation," he said. "I knew that this hadn't been tested on animals before. We were both the first human and first animal trials. Each day progressing to that one week point after the first injection, I felt more and more safe with what was going on."
Besides minor shoulder pain at the injection site, Browning and Haller say they never had any side effects.
"I feel fantastic, no side effects for me," said Haller.
Moderna tested three doses of the vaccine. Each participant got two injections, one month apart. Ian Haydon received the highest dose, ten times higher than Jennifer and Neal's low dose.
"After the first injection all I had was a little bit of arm pain in my shoulder where I got the shot, but for the second injection a month later, I did have some more issues. For about 24 hours, I had a fever, and a headache, some nausea, things like that," explained Haydon.
Haydon, a healthy 29-year-old, also fainted at home after a trip to urgent care. "I had some bloodwork done, they actually gave me a COVID-19 test because at the time it wasn't clear what was happening to me."
Haydon tested negative for COVID. "A couple days later it became clear that I had too much of an immune reaction to that high dose of the vaccine."
VIDEO: Californians explain why they won't be taking a COVID-19 vaccine when it comes out
Haydon says because of the side effects he and a few other high dose participants experienced, Moderna is no longer testing that 250 microgram dose. The company chose to move forward with Phase 3 trials using the middle 100 microgram dose, since the vaccine produced a "rapid and strong immune response" in all 45 people tested during phase 1, regardless of the dose they received.
"I've been following trial since Ian was one of first 45 people," said Sacramento resident, Judy Stokes.
Stokes is Haydon's mom. Inspired by her son, she signed up for Moderna's Phase 3 trial when it was announced in Sacramento.
"I really wasn't sure if they would want me," she said. "I'm 68-years-old and I have heart disease and I have high blood pressure, but it turns out that is exactly who they wanted. They wanted a diverse group of people and those more vulnerable to the virus."
She got her first injection last week and does not know if she received the vaccine or a placebo. "They are monitoring us and will be for two years, that's almost like an extra bonus."
Besides sore shoulders on injection day, all four participants share a similar outlook on the vaccine trials.
VIDEO: Which countries will get COVID-19 vaccine first?
"We all want a coronavirus vaccine, but we're not going to get one unless people volunteer to take part," said Haydon.
When reporter, Kate Larsen, asked Haller and Browning if they would volunteer again, Haller said, "Yeah, absolutely," and Browning responded, "Same here."
Stokes says whether it's the Moderna vaccine or another, she feels one of the trials will prove successful. "I feel hopeful, this one or another one, I feel hopeful."
You can find more information about the Bay Area's AstraZeneca trial, including how to enroll, by clicking here."
App users: For a better experience, click here to view the full map in a new window
If you have a question or comment about the coronavirus pandemic, submit yours via the form below or here.
Get the latest news, information and videos about the novel coronavirus pandemic here
RELATED STORIES & VIDEOS:
- COVID-19 Help: Comprehensive list of resources, information
- Watch list: Counties where COVID-19 is getting worse
- MAP: Everything that's open, forced to close in Bay Area
- Everything to know about CA's confusing reopening plan, summer shutdown and what comes next
- From salons to dinner parties: Experts rate the risk of 12 activities
- Coronavirus origin: Where did COVID-19 come from?
- Life after COVID-19: Here's what restaurants, gyms will look like
- What is a COVID-19 genetic, antigen and antibody test?
- What will it take to get a COVID-19 vaccine and how will it be made?
- What does COVID-19 do to your body and why does it spread so easily?
- Here's how shelter in place, stay at home orders can slow spread of COVID-19
- Coronavirus Timeline: Tracking major moments of COVID-19 pandemic in San Francisco Bay Area
- Experts compare face shield vs. face mask effectiveness
- COVID-19 Diaries: Personal stories of Bay Area residents during novel coronavirus pandemic
- Coronavirus Doctor's Note: Dr. Alok Patel gives his insight into COVID-19 pandemic